These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 1988416

  • 1. Buspirone in major depression: a controlled study.
    Rickels K, Amsterdam JD, Clary C, Puzzuoli G, Schweizer E.
    J Clin Psychiatry; 1991 Jan; 52(1):34-8. PubMed ID: 1988416
    [Abstract] [Full Text] [Related]

  • 2. Buspirone in depressed outpatients: a controlled study.
    Rickels K, Amsterdam J, Clary C, Hassman J, London J, Puzzuoli G, Schweizer E.
    Psychopharmacol Bull; 1990 Jan; 26(2):163-7. PubMed ID: 2236452
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH, Worthington JJ, Manfro GG, Otto MW, Zucker BG.
    J Clin Psychiatry; 1997 Jan; 58 Suppl 11():19-23. PubMed ID: 9363044
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Buspirone in the long-term treatment of generalized anxiety disorder.
    Feighner JP.
    J Clin Psychiatry; 1987 Dec; 48 Suppl():3-6. PubMed ID: 3320034
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E, Feighner J, Mandos LA, Rickels K.
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [Abstract] [Full Text] [Related]

  • 16. Possible augmentation of antidepressant response by buspirone.
    Jacobsen FM.
    J Clin Psychiatry; 1991 May; 52(5):217-20. PubMed ID: 2033029
    [Abstract] [Full Text] [Related]

  • 17. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
    Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, St Clair LS, Murphy JH, Haq N, Rubinow DR.
    Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
    [Abstract] [Full Text] [Related]

  • 18. Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder.
    Sheehan DV.
    J Clin Psychiatry; 1999 Feb; 60 Suppl 22():23-8. PubMed ID: 10634352
    [Abstract] [Full Text] [Related]

  • 19. Is buspirone effective for panic disorder?
    Sheehan DV, Raj AB, Sheehan KH, Soto S.
    J Clin Psychopharmacol; 1990 Feb; 10(1):3-11. PubMed ID: 2407755
    [Abstract] [Full Text] [Related]

  • 20. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW, Bystritsky A.
    J Clin Psychiatry; 1997 Feb; 58 Suppl 11():24-9. PubMed ID: 9363045
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.